NCT01230346

Brief Summary

This pilot clinical trial studies a culturally-informed counseling intervention in Latinas at high risk for hereditary breast or ovarian cancer. A culturally-informed counseling intervention may be an effective method to help people learn more about their cancer risk.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
493

participants targeted

Target at P75+ for not_applicable

Timeline
5mo left

Started Sep 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Sep 2010Sep 2026

Study Start

First participant enrolled

September 3, 2010

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

September 22, 2010

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 29, 2010

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 10, 2016

Completed
9.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 25, 2026

Expected
Last Updated

November 10, 2025

Status Verified

November 1, 2025

Enrollment Period

6.2 years

First QC Date

September 22, 2010

Last Update Submit

November 6, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Effect of pre-GCRA intervention versus a time and attention control versus standard scheduling procedure alone (usual) on levels of anxiety, perceived personal control and cancer genetic knowledge

    Tested using 3 x 3 repeated measures analysis of covariance (ANCOVA)s in which the within subjects variables are anxiety or perceived control, the between groups variable is group membership, and covariates include fatalism and other appropriate moderators.

    One week after genetic cancer risk assessment (GCRA)

  • Experiences with the pre-GCRA intervention through post-intervention telephone interviews

    One week after genetic cancer risk assessment (GCRA)

  • Conduct a randomized controlled trial of a culturally-informed pre-GCRA telephone intervention utilizing AMI techniques

    Will use a multivariate ANCOVA (MANCOVA) to test for group differences among all five preparedness scores, with step-down F ratios of each individual score, using fatalism and other moderators as covariates, as appropriate.

    One week after genetic cancer risk assessment (GCRA)

Secondary Outcomes (1)

  • Perceived barriers to GCRA through no-show telephone interviews

    One week after genetic cancer risk assessment (GCRA)

Study Arms (3)

Arm I

EXPERIMENTAL

Patients receive a culturally-informed adapted motivational interviewing telephone call.

Other: questionnaire administrationOther: survey administrationOther: counseling interventionOther: educational intervention

Arm II

EXPERIMENTAL

Patients participate in a controlled condition comprising a health habits intervention group.

Other: questionnaire administrationOther: survey administrationOther: counseling intervention

Arm III

ACTIVE COMPARATOR

Patients receive usual care comprising a standard scheduling phone call and proceed with normal GCRA process.

Other: questionnaire administrationOther: survey administration

Interventions

Ancillary studies

Arm IArm IIArm III

Ancillary studies

Arm IArm IIArm III

Telephone intervention

Also known as: counseling and communications studies
Arm IArm II

Telephone intervention

Also known as: intervention, educational
Arm I

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals who have a personal history of hereditary breast or ovarian cancer; a subset of 60 women without a personal history of hereditary or ovarian cancer will be included in an exploratory subset analysis
  • Meet NCCN criteria for consideration of genetic testing for hereditary breast cancer
  • Willing to sign consent
  • Pregnant women and women of child-bearing potential are eligible for participation in this study
  • Women who report themselves to be of Latino or Hispanic ethnic background (defined as Spanish, Mexican, Central or South American, Cuban, Puerto Rican, Dominican, or other Hispanic origin)
  • Women who are under- or uninsured and come from low-income communities
  • Ability to understand English or Spanish

You may not qualify if:

  • Previous participation in GCRA

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

City of Hope Medical Center

Duarte, California, 91010, United States

Location

University of Southern California-Keck School of Medicine

Los Angeles, California, 90033, United States

Location

Olive View-UCLA Medical Center

Sylmar, California, 91342, United States

Location

MeSH Terms

Interventions

CounselingEarly Intervention, EducationalMethods

Intervention Hierarchy (Ancestors)

Mental Health ServicesBehavioral Disciplines and ActivitiesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesChild Health ServicesPreventive Health ServicesInvestigative Techniques

Study Officials

  • Bita Nehoray

    City of Hope Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 22, 2010

First Posted

October 29, 2010

Study Start

September 3, 2010

Primary Completion

November 10, 2016

Study Completion (Estimated)

September 25, 2026

Last Updated

November 10, 2025

Record last verified: 2025-11

Locations